| Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors H Hanaoka, T Mukai, H Tamamura, T Mori, S Ishino, K Ogawa, Y Iida, ... Nuclear medicine and biology 33 (4), 489-494, 2006 | 138 | 2006 |
| Development of a novel 99mTc-chelate–conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent K Ogawa, T Mukai, Y Inoue, M Ono, H Saji Journal of Nuclear Medicine 47 (12), 2042-2047, 2006 | 130 | 2006 |
| Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT HH Yeh, K Ogawa, J Balatoni, U Mukhapadhyay, A Pal, ... Proceedings of the National Academy of Sciences 108 (4), 1603-1608, 2011 | 114 | 2011 |
| Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides H Akizawa, Y Arano, M Mifune, A Iwado, Y Saito, T Mukai, T Uehara, ... Nuclear medicine and biology 28 (7), 761-768, 2001 | 108 | 2001 |
| αvβ3 Integrin‐targeting radionuclide therapy and imaging with monomeric RGD peptide M Yoshimoto, K Ogawa, K Washiyama, N Shikano, H Mori, R Amano, ... International journal of cancer 123 (3), 709-715, 2008 | 95 | 2008 |
| Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals K Ogawa, T Mukai, Y Arano, M Ono, H Hanaoka, S Ishino, K Hashimoto, ... Bioconjugate chemistry 16 (4), 751-757, 2005 | 92 | 2005 |
| Rhemium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliation K Ogawa, T Mukai, Y Arano, A Otaka, M Ueda, T Uehara, Y Magata, ... Nuclear medicine and biology 33 (4), 513-520, 2006 | 85 | 2006 |
| Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor K Shiba, K Ogawa, K Ishiwata, K Yajima, H Mori Bioorganic & medicinal chemistry 14 (8), 2620-2626, 2006 | 67 | 2006 |
| Development of [90Y] DOTA-conjugated bisphosphonate for treatment of painful bone metastases K Ogawa, H Kawashima, K Shiba, K Washiyama, M Yoshimoto, Y Kiyono, ... Nuclear medicine and biology 36 (2), 129-135, 2009 | 65 | 2009 |
| Therapeutic effects of a 186Re-complex–conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model K Ogawa, T Mukai, D Asano, H Kawashima, S Kinuya, K Shiba, ... Journal of Nuclear Medicine 48 (1), 122-127, 2007 | 61 | 2007 |
| Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins M Ono, Y Arano, T Uehara, Y Fujioka, K Ogawa, S Namba, T Mukai, ... Bioconjugate chemistry 10 (3), 386-394, 1999 | 58 | 1999 |
| Radiotheranostics with radiolanthanides: Design, development strategies, and medical applications K Mishiro, H Hanaoka, A Yamaguchi, K Ogawa Coordination chemistry reviews 383, 104-131, 2019 | 57 | 2019 |
| Plasma protein binding of 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides M Ono, Y Arano, T Mukai, T Uehara, Y Fujioka, K Ogawa, S Namba, ... Nuclear medicine and biology 28 (2), 155-164, 2001 | 57 | 2001 |
| Bone target radiotracers for palliative therapy of bone metastases K Ogawa, K Washiyama Current medicinal chemistry 19 (20), 3290-3300, 2012 | 56 | 2012 |
| Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent K Ogawa, K Takai, H Kanbara, T Kiwada, Y Kitamura, K Shiba, A Odani Nuclear medicine and biology 38 (5), 631-636, 2011 | 52 | 2011 |
| 99mTc-HYNIC-derivatized ternary ligand complexes for 99mTc-labeled polypeptides with low in vivo protein binding M Ono, Y Arano, T Mukai, Y Fujioka, K Ogawa, T Uehara, T Saga, ... Nuclear medicine and biology 28 (3), 215-224, 2001 | 52 | 2001 |
| A Tc-99m-labeled long chain fatty acid derivative for myocardial imaging Y Magata, T Kawaguchi, M Ukon, N Yamamura, T Uehara, K Ogawa, ... Bioconjugate chemistry 15 (2), 389-393, 2004 | 51 | 2004 |
| Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers K Ogawa, A Ishizaki, K Takai, Y Kitamura, T Kiwada, K Shiba, A Odani PLoS One 8 (12), e84335, 2013 | 47 | 2013 |
| Radiotheranostics coupled between an At-211-labeled RGD peptide and the corresponding radioiodine-labeled RGD peptide K Ogawa, T Takeda, K Mishiro, A Toyoshima, K Shiba, T Yoshimura, ... Acs Omega 4 (3), 4584-4591, 2019 | 46 | 2019 |
| Technetium-99m-labeled medium-chain fatty acid analogues metabolized by β-oxidation: radiopharmaceutical for assessing liver function N Yamamura, Y Magata, Y Arano, T Kawaguchi, K Ogawa, J Konishi, ... Bioconjugate chemistry 10 (3), 489-495, 1999 | 46 | 1999 |
